Conzylum has been acquired by EPAM Systems, Inc.

Conzylum has been sold to EPAM Systems, Inc. (EPAM).

Conzylum is a boutique insurtech software development company that specializes in leveraging AI and advanced technologies to provide cutting-edge solutions. The company provides a comprehensive range of services, including portfolio services, business process optimization, calculation, data management, risk management and cloud management. With a focus on software integration, Conzylum collaborates with insurance firms, acting as a partner in the development and implementation of risk profiles based on extensive data analysis. By harnessing large datasets and advanced algorithms, Conzylum enables insurers to make informed decisions, enhance their underwriting processes and effectively manage risks.

Headquartered in Newtown, Pennsylvania, EPAM is a US-based global provider of software engineering and IT consulting services. Its teams of technologists, strategists and designers deliver powerful digital experiences. The company specializes in 11 industries across 55 countries and regions, delivering innovative solutions to its customers’ most challenging problems.

Oaklins’ team in Switzerland advised Conzylum’s owner and founder on the sell-side process.

SERVICIO

M&A sell-side

PARTES

“Oaklins supported me and my team throughout the entire, sometimes very intense, transaction phase with comprehensive expertise, being absolutely reliable and always goal-oriented. Oaklins’ experience, personal commitment and professionalism were a critical factor for the successful sale of my company.”

Peter Meyer

Founder and CEO, Conzylum

Contáctese con el equipo de la transacción

David Zürrer

Partner

Basel, Suiza
Oaklins Switzerland

Ver perfil Contáctenos

Dr. Jürg Stucker

Partner

Zurich, Suiza
Oaklins Switzerland

Ver perfil Contáctenos

Florian Mattern

Asociado

Zurich, Suiza
Oaklins Switzerland

Ver perfil Contáctenos

Transacciones relacionadas

Bayer AG has entered into a takeover agreement with Cara Care

Salud | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

Private Equity | Servicios de Soporte Comercial | Servicios Financieros | TMT

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.

Amber-Allen Publishing has sold its publishing assets to Penguin Publishing Group

TMT

Amber-Allen Publishing has sold its publishing assets to Penguin Publishing Group

Amber-Allen Publishing, home to some of the world’s most influential personal development books, most notably “The Four Agreements” by Don Miguel Ruiz and Janet Mills, has sold its publishing assets to Penguin Publishing Group. When the acquisition is complete, the Amber-Allen list will be managed by the TarcherPerigee imprint.